Apollomics (APLM) Non-Current Assets (2021 - 2025)
Apollomics (APLM) reported Non-Current Assets of $663000.0 for Q4 2025, down 95.86% quarter-over-quarter from $16.0 million in Q2 2023.
Apollomics (APLM) Non-Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has 4 years of Non-Current Assets data on file, last reported at $663000.0 in Q4 2025.
- Non-Current Assets for Q4 2025 came in at $663000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $663000.0 (changed N/A YoY), and the FY2025 annual result was $663000.0, changed N/A from the prior year.
- Non-Current Assets retreated to $663000.0 in Q4 2025 per APLM's latest filing, from $16.0 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $24.1 million in Q4 2021 and troughed at $663000.0 in Q4 2025.
- A 4-year average of $15.4 million and a median of $18.3 million in 2022 frame the typical range for Non-Current Assets.
- On a YoY basis, Non-Current Assets climbed as much as 14.06% in 2022 and fell as far as 14.06% in 2022.
- A 4-year view of Non-Current Assets shows it stood at $24.1 million in 2021, then fell by 14.06% to $20.7 million in 2022, then retreated by 22.63% to $16.0 million in 2023, then plunged by 95.86% to $663000.0 in 2025.
- Business Quant data shows APLM's Non-Current Assets at $663000.0 in Q4 2025, $16.0 million in Q2 2023, and $20.7 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 663,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 663,000.00 |
| Jun 30, 2023 | 16.00 Mn |
| Dec 31, 2022 | 20.69 Mn |
| Dec 31, 2021 | 24.07 Mn |